Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18794258rdf:typepubmed:Citationlld:pubmed
pubmed-article:18794258lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C0014822lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C0021308lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C0035126lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C0456389lld:lifeskim
pubmed-article:18794258lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:18794258pubmed:issue10lld:pubmed
pubmed-article:18794258pubmed:dateCreated2008-10-3lld:pubmed
pubmed-article:18794258pubmed:abstractTextAdministration of erythropoietin (EPO) during or immediately after myocardial ischemia can reduce subsequent myocardial apoptosis, a key phenomenon in myocardial ischemia-reperfusion injury. In this study, we assessed the effect of EPO on (99m)Tc-annexin V myocardial uptake and whether the accumulation of (99m)Tc-annexin V can predict cardiac remodeling and functional deterioration.lld:pubmed
pubmed-article:18794258pubmed:languageenglld:pubmed
pubmed-article:18794258pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18794258pubmed:citationSubsetIMlld:pubmed
pubmed-article:18794258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18794258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18794258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18794258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18794258pubmed:statusMEDLINElld:pubmed
pubmed-article:18794258pubmed:monthOctlld:pubmed
pubmed-article:18794258pubmed:issn0161-5505lld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:AzumaAkihiroAlld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:UedaMasashiMlld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:MatsubaraHiro...lld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:OgawaKazumaKlld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:SajiHideoHlld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:DoueTomokiTlld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:OhtsukiKatsui...lld:pubmed
pubmed-article:18794258pubmed:authorpubmed-author:StraussHarry...lld:pubmed
pubmed-article:18794258pubmed:issnTypePrintlld:pubmed
pubmed-article:18794258pubmed:volume49lld:pubmed
pubmed-article:18794258pubmed:ownerNLMlld:pubmed
pubmed-article:18794258pubmed:authorsCompleteYlld:pubmed
pubmed-article:18794258pubmed:pagination1694-700lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:meshHeadingpubmed-meshheading:18794258...lld:pubmed
pubmed-article:18794258pubmed:year2008lld:pubmed
pubmed-article:18794258pubmed:articleTitleCardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.lld:pubmed
pubmed-article:18794258pubmed:affiliationDepartment of Cardiology and Nephrology, Kyoto Prefectural University of Medicine, Kyoto, Japan. doue@meiji-u.ac.jplld:pubmed
pubmed-article:18794258pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18794258pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed